Logo

MolDx Program

Qlucore Raises SEK 30M as it Looks Toward IPO

The Swedish bioinformatics firm sees its greatest growth potential in precision cancer diagnostics as it prepares to go public in the next 12 months.

Natera Receives LCD From Palmetto for Signatera MRD Test in Colorectal Cancer Patients

The Medicare Administrative Contractor will cover ctDNA tests if the patient has a personal history of colorectal cancer.

After DNA-10K, NorthShore Looks to Expand Genomics Integration Into Primary Care
Premium

Working with clinical decision support vendor ActX, the suburban Chicago health system has seen strong demand for PGx and genetically informed preventive care.

Qlucore Expands Into Diagnostics, Precision Medicine With New Informatics Offering
Premium

The new Qlucore Diagnostics software builds on the recently updated Qlucore Omics Explorer platform, initially to help clinicians diagnose and treat leukemia.

CareDx Stock Spikes on News of MolDX Reimbursement of AlloSure

Piper Jaffray analyst William Quirk said the pricing, which was much higher than expected, will help push CareDx toward profitability.

Breaking News
The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.